| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |